Intravesical Bacillus Calmette-Gu&eacute rin (BCG) has become the preferred initial treatment after resection of high-grade T1 urothelial carcinoma and carcinoma in situ (CIS) We report the case of a patient with high-grade T1 urothelial carcinoma and CIS who was treated with intravesical BCG